imipramine has been researched along with venlafaxine hydrochloride in 55 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (1.82) | 18.7374 |
| 1990's | 11 (20.00) | 18.2507 |
| 2000's | 17 (30.91) | 29.6817 |
| 2010's | 23 (41.82) | 24.3611 |
| 2020's | 3 (5.45) | 2.80 |
| Authors | Studies |
|---|---|
| Haskins, JT; Husbands, GE; Moyer, JA; Muth, EA; Nielsen, ST; Sigg, EB | 1 |
| Preskorn, SH | 1 |
| Cohn, C; Crowder, J; Davidson, J; Dunner, D; Feighner, J; Kiev, A; Patrick, R; Shrivastava, RK | 1 |
| Bradley, MM; Entsuah, AR; Littman, GS | 1 |
| Feighner, J; Mandos, LA; Rickels, K; Schweizer, E | 1 |
| Benkert, O; Gründer, G; Schlösser, R; Wetzel, H | 1 |
| Ahern, D; Ball, SE; Kao, J; Scatina, J | 1 |
| Blanchard, C; Bourin, M; Danjou, P; Hackett, D; Lecrubier, Y; Moon, CA; Schifano, F | 1 |
| Rajagopalan, M | 1 |
| Béïque, JC; de Montigny, C; Debonnel, G; Lavoie, N | 1 |
| Thase, ME | 1 |
| Corruble, E; Guelfi, JD | 1 |
| Gómez Gómez, JM; Teixidó Perramón, C | 1 |
| Albers, LJ; Fujimoto, K; Helmeste, D; Ozdemir, V; Poland, R; Reist, C; Tang, SW; Vu, RL | 1 |
| Bosmans, E; Kenis, G; Kubera, M; Lin, AH; Maes, M; van Bockstaele, D | 1 |
| Dunn, AJ; Swiergiel, AH | 1 |
| Pallay, AG; Pedersen, RD; Rudolph, RL | 1 |
| Gorman, JM | 1 |
| Bach, FW; Gram, LF; Jensen, TS; Madsen, C; Sindrup, SH | 1 |
| Chodera, A; Kus, K; Nowakowska, E | 1 |
| Basta-Kaim, A; Bosmans, E; Budziszewska, B; Kajta, M; Kenis, G; Kubera, M; Maes, M; Scharpe, S | 1 |
| Bateman, DN; Chick, J; Good, AM; Kelly, CA; Masterton, G | 1 |
| Andrews, G; Carter, R; Donnelly, M; Haby, MM; Heuzenroeder, L; Mihalopoulos, C; Rossell, R; Vos, T | 1 |
| Cunha, A; Gazalle, FK; Kapczinski, F; Lima, MS; Schmitt, R; Souza, J | 1 |
| Higuchi, T; Honda, K; Kamijima, K; Kitahara, S; Tanaka, S; Yamada, M | 1 |
| Heerdink, ER; van Dijk, L; Volkers, AC | 1 |
| Hay-Schmidt, A; Larsen, MH; Mikkelsen, JD; Rønn, LC | 1 |
| Ara, A; Banu, N; Zafir, A | 1 |
| Birkenhäger, TK; Boks, MP; Breteler, LM; Bruijn, JA; Burger, H; Janzing, JG; Nolen, WA; Ramaekers, GM; van den Broek, WW; van der Loos, ML; Verkes, RJ; Wijkstra, J | 1 |
| Garg, R; Gaur, V; Kumar, A; Kumar, P | 1 |
| Birkenhäger, TK; Boks, MP; Breteler, LM; Bruijn, JA; Burger, H; Janzing, JG; Nolen, WA; van den Broek, WW; van der Loos, ML; Verkes, RJ; Wijkstra, J | 1 |
| Hay-Schmidt, A; Larsen, MH; Mikkelsen, JD; Sandi, C | 1 |
| Krass, M; Vasar, E; Volke, V; Wegener, G | 1 |
| Fisar, Z; Hroudová, J; Raboch, J | 1 |
| Fulda, S; Himmerich, H; Plümäkers, B; Rink, L; Sheldrick, AJ | 1 |
| Abbas, G; Dar, A; Naqvi, S | 1 |
| Holsboer, F; Perisic, T; Rein, T; Yu, S; Zimmermann, N; Zschocke, J | 1 |
| Birkenhäger, TK; Bruijn, JA; Mulder, PG; van den Broek, WW; Vermeiden, M | 1 |
| Cavender, HM; Cooke, JD; Grover, LM; Lima, HK | 1 |
| Birkenhäger, TK; Kamperman, AM; van den Broek, WW; Vermeiden, M; Vulink, ME | 1 |
| Bergink, V; Birkenhager, TK; Carvalho, LA; Drexhage, HA; Grosse, L; Hoogendijk, WJ; Kushner, SA | 1 |
| Buggy, DJ; Butler, M; Gallagher, HC; Gallagher, RM; Henman, MC | 1 |
| Alferink, J; Ambrée, O; Arolt, V; Bergink, V; Birkenhäger, TK; Drexhage, HA; Grosse, L; Rothermundt, M | 1 |
| Bagmetova, VV; Chernysheva, YV; Ozerov, AA; Tyurenkov, IN | 1 |
| Bryk, A; Bryniarski, P; Filipczak-Bryniarska, I; Kozlowski, M; Kuszmiersz, P; Myszka, M; Nazimek, K; Nowakowski, J; Strobel, S; Tyszka, A | 1 |
| Cipriani, A; Coghill, D; Cohen, D; Cuijpers, P; Del Giovane, C; Hazell, P; Hetrick, SE; Leucht, S; Liu, L; Liu, Y; Michael, KD; Pu, J; Qin, B; Ravindran, AV; Whittington, C; Xie, P; Yang, L; Zhang, Y; Zhou, X | 1 |
| Brand, SJ; Harvey, BH | 1 |
| Birkenhäger, TK; Hoogendijk, WJG; Kamperman, AM; van den Broek, WW; Vermeiden, M | 1 |
| Bach, FW; Demant, D; Finnerup, NB; Holbech, J; Jensen, TS; Sindrup, SH | 1 |
| Gruca, P; Lason, M; Litwa, E; Niemczyk, M; Papp, M; Tota-Glowczyk, K; Willner, P | 2 |
| Ishibashi, T; Iwadate, R; Kawai, H; Kawashima, Y; Kudo, N; Mitsumoto, A | 1 |
| Koziorowski, M; Mytych, J; Sołek, P; Tabęcka-Łonczyńska, A | 1 |
| Giles, R; Girard, MFC; Hopfgartner, G; Knight, P | 1 |
| Cao, Q; Rao, Y; Yang, R; Zhao, J | 1 |
8 review(s) available for imipramine and venlafaxine hydrochloride
| Article | Year |
|---|---|
Comparison of the tolerability of bupropion, fluoxetine, imipramine, nefazodone, paroxetine, sertraline, and venlafaxine.
Topics: 1-Naphthylamine; Antidepressive Agents; Bupropion; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Design; Drug Tolerance; Drugs, Investigational; Fluoxetine; Humans; Imipramine; Paroxetine; Piperazines; Selective Serotonin Reuptake Inhibitors; Sertraline; Triazoles; Venlafaxine Hydrochloride | 1995 |
[Is there a relationship between clinical efficacy and antidepressant dosage in major depression?].
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Humans; Imipramine; Selective Serotonin Reuptake Inhibitors; Venlafaxine Hydrochloride | 1999 |
Treating generalized anxiety disorder.
Topics: Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Benzodiazepines; Buspirone; Clinical Trials as Topic; Cognitive Behavioral Therapy; Cyclohexanols; Humans; Imipramine; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; United States; Venlafaxine Hydrochloride | 2003 |
Cost-effectiveness of psychological and pharmacological interventions for generalized anxiety disorder and panic disorder.
Topics: Antidepressive Agents, Tricyclic; Anxiety Disorders; Australia; Cost-Benefit Analysis; Cyclohexanols; Disability Evaluation; Humans; Imipramine; Mental Health Services; Panic Disorder; Paroxetine; Psychotherapy; Selective Serotonin Reuptake Inhibitors; Time Factors; Venlafaxine Hydrochloride | 2004 |
The efficacy of antidepressants for generalized anxiety disorder: a systematic review and meta-analysis.
Topics: Antidepressive Agents; Anxiety Disorders; Cyclohexanols; Female; Humans; Imipramine; Male; Paroxetine; Randomized Controlled Trials as Topic; Treatment Outcome; Venlafaxine Hydrochloride | 2005 |
Venlafaxine for neuropathic pain in adults.
Topics: Adult; Analgesics, Non-Narcotic; Antidepressive Agents, Second-Generation; Carbamazepine; Humans; Imipramine; Middle Aged; Neuralgia; Off-Label Use; Patient Dropouts; Randomized Controlled Trials as Topic; Venlafaxine Hydrochloride | 2015 |
Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Bayes Theorem; Child; Citalopram; Clomipramine; Confounding Factors, Epidemiologic; Depressive Disorder, Major; Desipramine; Double-Blind Method; Drug Administration Schedule; Duloxetine Hydrochloride; Evidence-Based Medicine; Fluoxetine; Humans; Imipramine; Mianserin; Mirtazapine; Nortriptyline; Paroxetine; Piperazines; Randomized Controlled Trials as Topic; Research Design; Sertraline; Treatment Outcome; Triazoles; Venlafaxine Hydrochloride | 2016 |
Efficacy and tolerability of antidepressant drugs in treatment of depression in children and adolescents: a network meta-analysis.
Topics: Adolescent; Amitriptyline; Antidepressive Agents; Child; Depression; Depressive Disorder, Major; Duloxetine Hydrochloride; Escitalopram; Fluoxetine; Humans; Imipramine; Network Meta-Analysis; Paroxetine; Sertraline; Venlafaxine Hydrochloride | 2022 |
17 trial(s) available for imipramine and venlafaxine hydrochloride
| Article | Year |
|---|---|
Long-term safety and clinical acceptability of venlafaxine and imipramine in outpatients with major depression.
Topics: Adult; Antidepressive Agents, Second-Generation; Cyclohexanols; Depressive Disorder; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Long-Term Care; Male; Venlafaxine Hydrochloride | 1994 |
Cumulative mean change procedure: application to a comparative trial of venlafaxine, imipramine, and placebo in the treatment of major depression.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Cyclohexanols; Data Interpretation, Statistical; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1994 |
Comparison of venlafaxine and imipramine in the acute treatment of major depression in outpatients.
Topics: Acute Disease; Adult; Ambulatory Care; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Humans; Imipramine; Male; Patient Dropouts; Placebos; Psychiatric Status Rating Scales; Treatment Outcome; Venlafaxine Hydrochloride | 1994 |
Subchronic antidepressant treatment with venlafaxine or imipramine and effects on blood pressure and heart rate: assessment by automatic 24-hour monitoring.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cyclohexanols; Depressive Disorder; Double-Blind Method; Female; Heart Rate; Humans; Imipramine; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 1996 |
Efficacy of venlafaxine in depressive illness in general practice.
Topics: Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety; Cyclohexanols; Depression; Double-Blind Method; Family Practice; Female; Humans; Imipramine; Male; Middle Aged; Placebo Effect; Prospective Studies; Social Adjustment; Treatment Outcome; Venlafaxine Hydrochloride | 1997 |
Comparison of venlafaxine and imipramine in depressive illness.
Topics: Adult; Aged; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Family Practice; Female; Humans; Imipramine; Male; Middle Aged; Patient Care Team; Treatment Outcome; Venlafaxine Hydrochloride | 1998 |
Combined treatment with venlafaxine and tricyclic antidepressants in depressed patients who had partial response to clomipramine or imipramine: initial findings.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Clomipramine; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imipramine; Male; Middle Aged; Selective Serotonin Reuptake Inhibitors; Treatment Outcome; Venlafaxine Hydrochloride | 2000 |
Effect of venlafaxine on imipramine metabolism.
Topics: Adult; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cross-Over Studies; Cyclohexanols; Cytochrome P-450 CYP2D6; Desipramine; Drug Interactions; Humans; Imipramine; Male; Middle Aged; Phenotype; Venlafaxine Hydrochloride | 2000 |
Can improvement in well-being and functioning be distinguished from depression improvement in antidepressant clinical trials?
Topics: Activities of Daily Living; Adult; Analysis of Variance; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Controlled Clinical Trials as Topic; Cyclohexanols; Depression; Factor Analysis, Statistical; Female; Humans; Imipramine; Male; Outcome Assessment, Health Care; Psychiatric Status Rating Scales; Psychometrics; Reproducibility of Results; Venlafaxine Hydrochloride | 2002 |
Venlafaxine versus imipramine in painful polyneuropathy: a randomized, controlled trial.
Topics: Adult; Aged; Analgesics, Non-Narcotic; Cross-Over Studies; Cyclohexanols; Diabetic Neuropathies; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Neuralgia; Neurotransmitter Uptake Inhibitors; Norepinephrine; Pain Measurement; Polyneuropathies; Pressure; Serotonin; Touch; Treatment Outcome; Venlafaxine Hydrochloride | 2003 |
Treatment of unipolar psychotic depression: a randomized, double-blind study comparing imipramine, venlafaxine, and venlafaxine plus quetiapine.
Topics: Adolescent; Adult; Affective Disorders, Psychotic; Aged; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Cyclohexanols; Depressive Disorder; Dibenzothiazepines; Double-Blind Method; Drug Administration Schedule; Drug Dosage Calculations; Drug Therapy, Combination; Female; Humans; Imipramine; Male; Middle Aged; Quetiapine Fumarate; Remission Induction; Selective Serotonin Reuptake Inhibitors; Severity of Illness Index; Treatment Outcome; Venlafaxine Hydrochloride; Young Adult | 2010 |
Long-term response to successful acute pharmacological treatment of psychotic depression.
Topics: Adult; Affective Disorders, Psychotic; Antidepressive Agents; Antipsychotic Agents; Cyclohexanols; Depressive Disorder, Major; Dibenzothiazepines; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Imipramine; Long-Term Care; Male; Middle Aged; Netherlands; Quetiapine Fumarate; Treatment Outcome; Venlafaxine Hydrochloride | 2010 |
A double-blind randomized study comparing plasma level-targeted dose imipramine and high-dose venlafaxine in depressed inpatients.
Topics: Adult; Aged; Aged, 80 and over; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Imipramine; Inpatients; Male; Middle Aged; Psychiatric Status Rating Scales; Venlafaxine Hydrochloride | 2013 |
Early improvement as a predictor of eventual antidepressant treatment response in severely depressed inpatients.
Topics: Adult; Aged; Antidepressive Agents; Cyclohexanols; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Double-Blind Method; Female; Humans; Imipramine; Male; Middle Aged; Predictive Value of Tests; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
S100B Serum Levels Predict Treatment Response in Patients with Melancholic Depression.
Topics: Adult; Aged; Antidepressive Agents; Biomarkers; Blood Chemical Analysis; Depressive Disorder; False Negative Reactions; Female; Humans; Imipramine; Linear Models; Male; Middle Aged; Prognosis; Psychiatric Status Rating Scales; S100 Calcium Binding Protein beta Subunit; Severity of Illness Index; Time Factors; Treatment Outcome; Venlafaxine Hydrochloride | 2015 |
A randomized clinical trial comparing two two-phase treatment strategies for in-patients with severe depression.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Major; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Imipramine; Lithium Compounds; Male; Middle Aged; Outcome Assessment, Health Care; Severity of Illness Index; Venlafaxine Hydrochloride | 2017 |
Impact of etiology and duration of pain on pharmacological treatment effects in painful polyneuropathy.
Topics: Adult; Aged; Anticonvulsants; Antidepressive Agents; Carbamazepine; Diabetic Neuropathies; Female; Humans; Imipramine; Male; Middle Aged; Neuralgia; Oxcarbazepine; Polyneuropathies; Pregabalin; Retrospective Studies; Time Factors; Venlafaxine Hydrochloride | 2017 |
30 other study(ies) available for imipramine and venlafaxine hydrochloride
| Article | Year |
|---|---|
Antidepressant biochemical profile of the novel bicyclic compound Wy-45,030, an ethyl cyclohexanol derivative.
Topics: Animals; Antidepressive Agents, Tricyclic; Biological Assay; Brain; Cyclohexanols; Desipramine; Dopamine; Guinea Pigs; Imipramine; Monoamine Oxidase Inhibitors; Muscle Contraction; Norepinephrine; Rats; Serotonin; Synaptosomes; Venlafaxine Hydrochloride | 1986 |
Venlafaxine: in vitro inhibition of CYP2D6 dependent imipramine and desipramine metabolism; comparative studies with selected SSRIs, and effects on human hepatic CYP3A4, CYP2C9 and CYP1A2.
Topics: 1-Naphthylamine; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Aryl Hydrocarbon Hydroxylases; Chromatography, High Pressure Liquid; Cyclohexanols; Cytochrome P-450 CYP1A2; Cytochrome P-450 CYP1A2 Inhibitors; Cytochrome P-450 CYP2C9; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Cytochrome P-450 CYP3A; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Desipramine; Fluoxetine; Fluvoxamine; Frozen Sections; Humans; Hydroxylation; Imipramine; In Vitro Techniques; Lethal Dose 50; Microsomes, Liver; Mixed Function Oxygenases; Paroxetine; Selective Serotonin Reuptake Inhibitors; Sertraline; Steroid 16-alpha-Hydroxylase; Steroid Hydroxylases; Venlafaxine Hydrochloride | 1997 |
Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters.
Topics: Animals; Antidepressive Agents, Second-Generation; Binding, Competitive; Brain; Carrier Proteins; Cyclohexanols; Fluoxetine; Imipramine; Male; Membrane Glycoproteins; Membrane Transport Proteins; Nerve Tissue Proteins; Neurotransmitter Uptake Inhibitors; Norepinephrine; Norepinephrine Plasma Membrane Transport Proteins; Radioligand Assay; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Antagonists; Serotonin Plasma Membrane Transport Proteins; Symporters; Venlafaxine Hydrochloride | 1998 |
Redefining antidepressant efficacy toward long-term recovery.
Topics: Antidepressive Agents; Antidepressive Agents, Second-Generation; Clinical Trials as Topic; Cyclohexanols; Depressive Disorder; Drug Administration Schedule; Goals; Humans; Imipramine; Longitudinal Studies; Placebos; Risk Factors; Secondary Prevention; Treatment Outcome; Venlafaxine Hydrochloride | 1999 |
Anti-Inflammatory effects of antidepressants through suppression of the interferon-gamma/interleukin-10 production ratio.
Topics: 5-Hydroxytryptophan; Adult; Analysis of Variance; Antidepressive Agents; Cyclohexanols; Depressive Disorder; Female; Fluoxetine; Humans; Imipramine; Interferon-gamma; Interleukin-10; Male; Middle Aged; Venlafaxine Hydrochloride | 2001 |
The reductions in sweetened milk intake induced by interleukin-1 and endotoxin are not prevented by chronic antidepressant treatment.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Appetite; Body Weight; Brain; Cyclohexanols; Depression; Dose-Response Relationship, Drug; Drug Administration Schedule; Eating; Imipramine; Interleukin-1; Lipopolysaccharides; Male; Mice; Milk; Neuroimmunomodulation; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Venlafaxine Hydrochloride | 2001 |
Comparison of behavioural effects of venlafaxine and imipramine in rats.
Topics: Animals; Anti-Anxiety Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Behavior, Animal; Cyclohexanols; Imipramine; Male; Maze Learning; Memory, Short-Term; Motor Activity; Rats; Rats, Wistar; Swimming; Venlafaxine Hydrochloride | 2003 |
Stimulatory effect of antidepressants on the production of IL-6.
Topics: 5-Hydroxytryptophan; Adult; Age Factors; Aging; Antidepressive Agents; Blood Cells; Cyclohexanols; Depressive Disorder; Drug Combinations; Female; Fluoxetine; Humans; Imipramine; In Vitro Techniques; Inflammation; Interleukin-6; Male; Middle Aged; Tumor Necrosis Factor-alpha; Venlafaxine Hydrochloride | 2004 |
Are selective serotonin re-uptake inhibitors associated with an increased risk of self-harm by antidepressant overdose?
Topics: Adult; Amitriptyline; Antidepressive Agents, Tricyclic; Citalopram; Cyclohexanols; Doxepin; Drug Overdose; Drug Prescriptions; Emergency Service, Hospital; Female; Fluoxetine; Humans; Imipramine; Information Services; Male; Mianserin; Mirtazapine; Paroxetine; Patient Admission; Patient Readmission; Poison Control Centers; Retrospective Studies; Risk Assessment; Scotland; Selective Serotonin Reuptake Inhibitors; Self-Injurious Behavior; Sertraline; Trazodone; Venlafaxine Hydrochloride | 2004 |
Induction of neuroserpin expression in rat frontal cortex after chronic antidepressant treatment and electroconvulsive treatment.
Topics: Animals; Antidepressive Agents; Cyclohexanols; Electroconvulsive Therapy; Expressed Sequence Tags; Fluoxetine; Frontal Lobe; Imipramine; Male; Neuropeptides; Neuroserpin; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA, Messenger; Serpins; Sertraline; Venlafaxine Hydrochloride | 2006 |
Antidepressant use and off-label prescribing in children and adolescents in Dutch general practice (2001-2005).
Topics: Adolescent; Adrenergic Uptake Inhibitors; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Anxiety Disorders; Attention Deficit Disorder with Hyperactivity; Child; Cyclohexanols; Depressive Disorder; Drug Labeling; Drug Prescriptions; Drug Utilization; Family Practice; Female; Humans; Imipramine; Male; Netherlands; Nocturnal Enuresis; Paroxetine; Practice Patterns, Physicians'; Selective Serotonin Reuptake Inhibitors; Tension-Type Headache; Time Factors; Venlafaxine Hydrochloride | 2007 |
Temporal expression of brain-derived neurotrophic factor (BDNF) mRNA in the rat hippocampus after treatment with selective and mixed monoaminergic antidepressants.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclohexanols; Dentate Gyrus; Fluoxetine; GAP-43 Protein; Hippocampus; Imipramine; Male; Neuronal Plasticity; Neurotransmitter Uptake Inhibitors; Rats; Rats, Sprague-Dawley; RNA, Messenger; Synaptophysin; Time Factors; Transcription, Genetic; Venlafaxine Hydrochloride | 2008 |
Invivo antioxidant status: a putative target of antidepressant action.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antioxidants; Body Weight; Cyclohexanols; Depressive Disorder; Fluvoxamine; Food Preferences; Imipramine; Lipid Peroxidation; Protein Carbonylation; Rats; Restraint, Physical; Stress, Psychological; Swimming; Taste; Venlafaxine Hydrochloride | 2009 |
Nitric oxide mechanism in protective effect of imipramine and venlafaxine against acute immobilization stress-induced behavioral and biochemical alteration in mice.
Topics: Animals; Antidepressive Agents; Anxiety; Arginine; Behavior, Animal; Cyclohexanols; Drug Synergism; Imipramine; Immobilization; Mice; Motor Activity; NG-Nitroarginine Methyl Ester; Nitric Oxide; Oxidative Stress; Pain Measurement; Stress, Psychological; Venlafaxine Hydrochloride | 2009 |
Regulation of brain-derived neurotrophic factor (BDNF) in the chronic unpredictable stress rat model and the effects of chronic antidepressant treatment.
Topics: Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; CA3 Region, Hippocampal; Cyclohexanols; Dentate Gyrus; Disease Models, Animal; Food Preferences; Hippocampus; Imipramine; In Situ Hybridization; Locomotion; Male; Maze Learning; Rats; Rats, Sprague-Dawley; RNA, Messenger; Saccharin; Stress, Psychological; Sweetening Agents; Swimming; Time Factors; Venlafaxine Hydrochloride | 2010 |
The antidepressant action of imipramine and venlafaxine involves suppression of nitric oxide synthesis.
Topics: Analysis of Variance; Animals; Antidepressive Agents; Behavior, Animal; Cyclohexanols; Depression; Disease Models, Animal; Imipramine; Male; Mice; Mice, Inbred C57BL; Motor Activity; Nitric Oxide; Swimming; Venlafaxine Hydrochloride | 2011 |
Inhibition of monoamine oxidase activity by antidepressants and mood stabilizers.
Topics: Affect; Amitriptyline; Animals; Antidepressive Agents; Antimanic Agents; Benzodiazepines; Cerebral Cortex; Citalopram; Clorgyline; Cocaine; Cyclohexanols; Desipramine; Fluoxetine; Imipramine; In Vitro Techniques; Iproniazid; Lithium; Mianserin; Mirtazapine; Mitochondria; Moclobemide; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Morpholines; Olanzapine; Pargyline; Reboxetine; Swine; Thiazepines; Valproic Acid; Venlafaxine Hydrochloride | 2010 |
IFN-gamma reduction by tricyclic antidepressants.
Topics: Amitriptyline; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cyclohexanols; Cytokines; Depressive Disorder; Desipramine; Desvenlafaxine Succinate; Female; Humans; Imipramine; In Vitro Techniques; Interferon-gamma; Male; Nortriptyline; Venlafaxine Hydrochloride | 2010 |
Comparison of monoamine reuptake inhibitors for the immobility time and serotonin levels in the hippocampus and plasma of sub-chronically forced swim stressed rats.
Topics: Adrenergic Uptake Inhibitors; Animals; Cyclohexanols; Fluoxetine; Hippocampus; Imipramine; Immobilization; Male; Rats; Rats, Sprague-Dawley; Selective Serotonin Reuptake Inhibitors; Serotonin; Stress, Psychological; Swimming; Venlafaxine Hydrochloride | 2012 |
Antidepressants inhibit DNA methyltransferase 1 through reducing G9a levels.
Topics: Animals; Antidepressive Agents; Astrocytes; Carbamazepine; Cells, Cultured; Cerebral Cortex; Citalopram; Cyclohexanols; DNA (Cytosine-5-)-Methyltransferase 1; DNA (Cytosine-5-)-Methyltransferases; DNA Methylation; Enzyme Inhibitors; Glycolipids; Histone-Lysine N-Methyltransferase; Imipramine; Indoles; Maleimides; Mice; Nerve Tissue Proteins; Neural Stem Cells; Neurons; Paroxetine; Protein Interaction Mapping; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Venlafaxine Hydrochloride | 2012 |
Antidepressants that inhibit both serotonin and norepinephrine reuptake impair long-term potentiation in hippocampus.
Topics: Adrenergic Uptake Inhibitors; Animals; Antidepressive Agents; Brain-Derived Neurotrophic Factor; Cyclohexanols; Fluoxetine; Hippocampus; Imipramine; Long-Term Potentiation; Male; Maprotiline; Norepinephrine; Selective Serotonin Reuptake Inhibitors; Serotonin; Synaptic Transmission; Venlafaxine Hydrochloride | 2014 |
Circulating cytotoxic T cells and natural killer cells as potential predictors for antidepressant response in melancholic depression. Restoration of T regulatory cell populations after antidepressant therapy.
Topics: Adult; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Depressive Disorder, Major; Diagnostic and Statistical Manual of Mental Disorders; Female; Flow Cytometry; Humans; Imipramine; Killer Cells, Natural; Lymphocyte Count; Male; Middle Aged; Predictive Value of Tests; Psychiatric Status Rating Scales; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory; Treatment Outcome; Venlafaxine Hydrochloride | 2016 |
Comparison of the Efficiency of Adeprophen and Antidepressants of Various Groups on the Model of Reserpine-Induced Depression in Rats.
Topics: Adenine; Amitriptyline; Animals; Antidepressive Agents; Behavior, Animal; Depression; Disease Models, Animal; Fluoxetine; Food Preferences; Imipramine; Male; Motor Activity; Paroxetine; Rats; Reserpine; Sertraline; Venlafaxine Hydrochloride | 2016 |
Repeatedly administered antidepressant drugs modulate humoral and cellular immune response in mice through action on macrophages.
Topics: Animals; Antidepressive Agents; Biomarkers; Cytokines; Depressive Disorder; Dermatitis, Contact; Fluoxetine; Imipramine; Immunity, Cellular; Immunity, Humoral; Immunosuppression Therapy; Injections, Intraperitoneal; Macrophages; Male; Mice; Mice, Inbred Strains; Moclobemide; Venlafaxine Hydrochloride | 2016 |
Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Cerebral Cortex; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Drug Synergism; Drug Therapy, Combination; Imipramine; Ketamine; Male; Rats; Rats, Transgenic; Stress Disorders, Post-Traumatic; Venlafaxine Hydrochloride | 2017 |
Rapid antidepressant effects of deep brain stimulation of the pre-frontal cortex in an animal model of treatment-resistant depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Deep Brain Stimulation; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Imipramine; Male; Prefrontal Cortex; Rats; Rats, Wistar; Stress, Psychological; Venlafaxine Hydrochloride | 2018 |
Validation of chronic mild stress in the Wistar-Kyoto rat as an animal model of treatment-resistant depression.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Citalopram; Depression; Depressive Disorder; Depressive Disorder, Treatment-Resistant; Disease Models, Animal; Imipramine; Ketamine; Male; Prefrontal Cortex; Rats; Rats, Inbred WKY; Rats, Wistar; Stress, Psychological; Venlafaxine Hydrochloride | 2019 |
Antidepressants with different mechanisms of action show different chronopharmacological profiles in the tail suspension test in mice.
Topics: Animals; Antidepressive Agents; Behavior, Animal; Bupropion; Circadian Rhythm; Depression; Dopamine; Fluoxetine; Imipramine; Male; Mice; Mice, Inbred C57BL; Movement; Norepinephrine; Time Factors; Venlafaxine Hydrochloride | 2019 |
Molecular Consequences of Depression Treatment: A Potential In Vitro Mechanism for Antidepressants-Induced Reprotoxic Side Effects.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antipsychotic Agents; Cell Line; Escitalopram; Fluoxetine; G2 Phase Cell Cycle Checkpoints; Gene Expression Regulation; Imipramine; Male; Mice; Micronuclei, Chromosome-Defective; Mirtazapine; Models, Biological; Olanzapine; Organ Specificity; Reboxetine; Reproduction; Signal Transduction; Spermatogenesis; Telomeric Repeat Binding Protein 1; Telomeric Repeat Binding Protein 2; Time Factors; Venlafaxine Hydrochloride | 2021 |
Effects of the LC mobile phase in vacuum differential mobility spectrometry-mass spectrometry for the selective analysis of antidepressant drugs in human plasma.
Topics: Acetonitriles; Amitriptyline; Antidepressive Agents; Desipramine; Humans; Imipramine; Maprotiline; Mass Spectrometry; Methanol; Nortriptyline; Reproducibility of Results; Spectrum Analysis; Vacuum; Venlafaxine Hydrochloride | 2022 |